Dehydrocostus lactone

Name: Dehydrocostus lactone
Brand: SIAL

analytical standard

Synonym(s):

(−)-Dehydrocostus lactone; Dehydrocostus lactone; Epiligulyl oxide, (3aS,6aR,9aR,9bS)-Decahydro-3,6,9-tris(methylene)-azuleno[4,5-b]furan-2(3H)-one, Dehydro-costus lactone (6CI,7CI), Dehydrocostuslactone, Guaia-4(15),10(14),11(13)-trien-12-oic acid, 6alpha-hydroxy-, gamma-lactone, [3aS-(3aα,6aα,9aα,9bβ)]-Decahydro-3,6,9-tris(methylene)-azuleno[4,5-b]furan-2(3H)-one

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

C₁₅H₁₈O₂

CAS Number:

477-43-0

Molecular Weight:

230.30

NACRES:

NA.24

PubChem Substance ID:

329756240

UNSPSC Code:

85151701

MDL number:

MFCD00210277

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

grade

analytical standard

Quality Level

100

assay

≥98.0% (GC)

optical activity

[α]/D -14.0±3.0°, c = 1 in chloroform

shelf life

limited shelf life, expiry date on the label

impurities

≤2.0% water

format

neat

storage temp.

−20°C

SMILES string

C=C1CC[C@@]2([H])C(CC[C@@H]3[C@H](OC(C3=C)=O)[C@]21[H])=C

InChI

1S/C15H18O2/c1-8-4-7-12-10(3)15(16)17-14(12)13-9(2)5-6-11(8)13/h11-14H,1-7H2/t11-,12-,13-,14-/m0/s1

InChI key

NETSQGRTUNRXEO-XUXIUFHCSA-N

Description

Biochem/physiol Actions

Dehydrocostuslactone (DHE) is a sesquiterpene lactone extracted from Saussurea lappa and Aucklandia lappa. The compound possess antifungal and antimycobacterial activity and exhibit a cytotoxic effect against HepG2, OVCAR-3, and HeLa cell lines.

Suppressors of cytokine signaling (SOCS) proteins negatively regulate cytokine receptor signaling. The SOCS family include eight members SOCS-1 to SOCS-7 and CIS. Dehydrocostuslactone (DHE) is a sesquiterpene lactone extracted from Saussurea lappa and Aucklandia lappa. The compound possess antifungal and antimycobacterial activity and exhibit a cytotoxic effect against HepG2, OVCAR-3, and HeLa cell lines. DHE inhibits cell proliferation not only in early-stage breast cancer MCF-7 but also in more advanced stage MDA-MB-231 cancer cells, without significant effect on H184B5F5/M10 normal mammary epithelial cells. The inhibition of breast cancer cells proliferation occurs through cell cycle blockade and apoptosis. DHE inhibits cell cycle progression and cell death through SOCS-1 and SOCS-3.